Brivaracetam

Therapeutic Group

Anti-epileptics

Indication Dosage

Indicated for partial-onset seizures

50 mg PO/IV q12hr initially; based on individual patient tolerability and therapeutic response, adjust dose between 25-100 mg PO/IV BID (50-200 mg/day)

The injection may be used for patients when oral administration is temporarily not feasible; clinical study experience with injection is limited to 4 consecutive days of treatment

For partial onset seizures:

  • Adults and children 16 years of age and older - At first, 50 milligrams (mg) 2 times a day. Your doctor may adjust your dose as needed and tolerated. However, the dose is usually not more than 100 mg 2 times a day.
  • Children 1 month to less than 16 years of age - Dose is based on body weight and must be determined by your doctor

 

Content

  • Tab 10mg, 25mg, 50mg, 75mg, 100mg

Pregnancy

No adequate and well-controlled studies in pregnant women

Stability

  • Anti-Convulsant
  • Anti-Epileptic

Contra Indications

  • It is contraindicated in patients with a prior hypersensitivity reaction to brivaracetam

Precautions

  • It is contraindicated in patients with a prior hypersensitivity reaction to brivaracetam

Lactation

  • Unknown if distributed in human breast milk

Side Effects

  • Somnolence
  • Sedation
  • Dizziness
  • Fatigue
  • Nausea and vomiting
  • Cerebellar coordination and balance disturbances
  • Irritability
  • Constipation

Available Brands